SuviCa is pleased to announce that it has been selected to present at the Rocky Mountain Life Science Investor & Partnering Conference to be held September 18-19 at the Ritz-Carlton Hotel in Denver, Colorado. For full story see: http://www.cobioscience.com/news-1/presenting-companies-announced.
SuviCa advisor on preclinical pharmacology, Dr. Daniel Gustafson, named CSU Shipley University Chair in Comparative Oncology. For full story see: http://www.today.colostate.edu.
November Focus 2012 PDF
Colorado BioScience Association
NY Venture Summit 2012
Colorado Biz Magazine PDF
SuviCa Inc, Names Jay T. Backstrom, M.D. To Board of Directors Boulder, Colo. – Feb 23, 2012 – Cancer drug discovery and development company SuviCa Inc. announced today that it has elected Jay T. Backstrom, M.D. to its Board of Directors. Dr. Backstrom is a veteran of the pharmaceutical industry with more than 20 years […]
Daily Camera Article RxPG News Examiner.com’s Coverage
Tech Transfer Office press release